Engineered Exosomes-Mediated Transfer of hsa-miR-320a Overcomes Chemoresistance in Cervical Cancer Cells via Targeting MCL1

In cervical cancer (CC), cisplatin resistance greatly restricts the application in clinical. Here, we report that engineered exosomes-mediated transfer of hsa-miR-320a overcomes chemoresistance in cervical cancer cells via targeting Myeloid Cell Leukemia Sequence 1 (MCL1). In DDP resistant CC tissue...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jinling, Wang, Yuanhe, Zhang, Lizhu, Chen, Qin, Zhu, Xiaojun, Jiang, Peiyue, Jiang, Nan, Zhao, Wei, Li, Baohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013939/
https://www.ncbi.nlm.nih.gov/pubmed/35444548
http://dx.doi.org/10.3389/fphar.2022.883445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013939/
https://www.ncbi.nlm.nih.gov/pubmed/35444548
http://dx.doi.org/10.3389/fphar.2022.883445

Ejemplares similares